Establish Retatrutide first, then add Cagrilintide
The medication, the dose, and the long-term plan must align with the patient not social media trends. This patient-first approach is what leads to safer treatment and sustainable results
If you have heart failure, advanced kidney disease, or other conditions requiring fluid restriction, seek personalised advice from your healthcare provider
GLP-1 therapy, while non-invasive, carries risks tied to long-term dependency and potential side effects
For maximum effectiveness, the treatment typically requires ongoing use over several months, during which cumulative results tend to become more apparent
Individual results vary based on starting weight, metabolic health, adherence to the protocol, and lifestyle factors